scispace - formally typeset
Search or ask a question
Author

Takashi Yorifuji

Bio: Takashi Yorifuji is an academic researcher from Okayama University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 32, co-authored 175 publications receiving 3582 citations. Previous affiliations of Takashi Yorifuji include Public Policy Institute of California & Harvard University.


Papers
More filters
Journal ArticleDOI
TL;DR: The results of these analyses, and the decision of the IARC Working Group to classify PM and outdoor air pollution as carcinogenic (Group 1), further justify efforts to reduce exposures to air pollutants that can arise from many sources.
Abstract: Background: Particulate matter (PM) in outdoor air pollution was recently designated a Group I carcinogen by the International Agency for Research on Cancer (IARC). This determination was based on ...

744 citations

Journal ArticleDOI
TL;DR: Although no clear association was found between sleep quality and mortality, long sleep duration was associated with higher risk of CVD mortality among those with poor sleep quality.

157 citations

Journal ArticleDOI
Christopher J. Portier, Bruce K. Armstrong1, Bruce C. Baguley2, Xaver Baur3, Igor Belyaev4, Robert Bellé5, Fiorella Belpoggi, Annibale Biggeri6, Maarten C. Bosland7, Paolo Bruzzi, Lygia T. Budnik8, Merete Drevvatne Bugge9, Kathleen Burns, Gloria M. Calaf10, David O. Carpenter11, Hillary M. Carpenter, Lizbeth López-Carrillo, Richard W. Clapp12, Pierluigi Cocco13, Dario Consonni, Pietro Comba14, Elena Craft15, Mohamed Aqiel Dalvie16, Devra Lee Davis17, Paul A. Demers18, Anneclaire J. De Roos19, Jamie C. DeWitt20, Francesco Forastiere, Jonathan H. Freedman21, Lin Fritschi22, Caroline Gaus23, Julia M. Gohlke24, Marcel Goldberg25, Eberhard Greiser, Johnni Hansen, Lennart Hardell, Michael Hauptmann26, Wei Huang27, James Huff28, Margaret O. James29, C. W. Jameson, Andreas Kortenkamp30, Annette Kopp-Schneider31, Hans Kromhout32, Marcelo L. Larramendy33, Philip J. Landrigan34, Lawrence H. Lash35, Dariusz Leszczynski36, Charles F. Lynch37, Corrado Magnani38, Daniele Mandrioli, Francis Martin39, Enzo Merler40, Paola Michelozzi, Lucia Miligi, Anthony B. Miller18, Dario Mirabelli41, Franklin E. Mirer42, Saloshni Naidoo43, Melissa J. Perry44, Maria Grazia Petronio, Roberta Pirastu45, Ralph J. Portier46, Kenneth S. Ramos47, Larry W. Robertson37, Theresa Rodriguez48, Martin Röösli49, Matthew K. Ross50, Deodutta Roy51, Ivan Rusyn52, Paulo Hilário Nascimento Saldiva53, Jennifer Sass44, Kai Savolainen54, Paul T.J. Scheepers55, Consolato Sergi56, Ellen K. Silbergeld57, Martyn T. Smith58, Bernard W. Stewart59, Patrice Sutton60, Fabio Tateo61, Benedetto Terracini41, Heinz W. Thielmann62, David B. Thomas63, Harri Vainio64, John E. Vena65, Paolo Vineis66, Elisabete Weiderpass67, Dennis D. Weisenburger68, Tracey J. Woodruff60, Takashi Yorifuji69, Il Je Yu70, Paola Zambon71, Hajo Zeeb72, Shu-Feng Zhou73 
University of Sydney1, University of Auckland2, Charité3, Slovak Academy of Sciences4, Centre national de la recherche scientifique5, University of Florence6, University of Illinois at Chicago7, University of Hamburg8, National Institute of Occupational Health9, University of Tarapacá10, University at Albany, SUNY11, Boston University12, University of Cagliari13, Istituto Superiore di Sanità14, Environmental Defense Fund15, University of Cape Town16, Hebrew University of Jerusalem17, University of Toronto18, Drexel University19, East Carolina University20, University of Louisville21, Curtin University22, University of Queensland23, Virginia Tech24, University of Paris25, Netherlands Cancer Institute26, Peking University27, National Institutes of Health28, University of Florida29, Brunel University London30, German Cancer Research Center31, Utrecht University32, National University of La Plata33, Icahn School of Medicine at Mount Sinai34, Wayne State University35, University of Helsinki36, University of Iowa37, University of Eastern Piedmont38, Lancaster University39, National Health Service40, University of Turin41, City University of New York42, University of KwaZulu-Natal43, George Washington University44, Sapienza University of Rome45, Louisiana State University46, University of Arizona47, National Autonomous University of Nicaragua48, University of Basel49, Mississippi State University50, Florida International University51, Texas A&M University52, University of São Paulo53, Finnish Institute of Occupational Health54, Radboud University Nijmegen55, University of Alberta56, Johns Hopkins University57, University of California, Berkeley58, University of New South Wales59, University of California, San Francisco60, National Research Council61, Heidelberg University62, University of Washington63, Kuwait University64, Medical University of South Carolina65, Imperial College London66, University of Tromsø67, City of Hope National Medical Center68, Okayama University69, Hoseo University70, University of Padua71, Leibniz Association72, University of South Florida73
TL;DR: The International Agency for Research on Cancer (IARC) Monographs Programme identifies chemicals, drugs, mixtures, occupational exposures, lifestyles and personal habits, and physical and biological agents that cause cancer in humans and has evaluated about 1000 agents since 1971.
Abstract: The International Agency for Research on Cancer (IARC) Monographs Programme identifies chemicals, drugs, mixtures, occupational exposures, lifestyles and personal habits, and physical and biological agents that cause cancer in humans and has evaluated about 1000 agents since 1971. Monographs are written by ad hoc Working Groups (WGs) of international scientific experts over a period of about 12 months ending in an eight-day meeting. The WG evaluates all of the publicly available scientific information on each substance and, through a transparent and rigorous process,1 decides on the degree to which the scientific evidence supports that substance's potential to cause or not cause cancer in humans. For Monograph 112,2 17 expert scientists evaluated the carcinogenic hazard for four insecticides and the herbicide glyphosate.3 The WG concluded that the data for glyphosate meet the criteria for classification as a probable human carcinogen . The European Food Safety Authority (EFSA) is the primary agency of the European Union for risk assessments regarding food safety. In October 2015, EFSA reported4 on their evaluation of the Renewal Assessment Report5 (RAR) for glyphosate that was prepared by the Rapporteur Member State, the German Federal Institute for Risk Assessment (BfR). EFSA concluded that ‘glyphosate is unlikely to pose a carcinogenic hazard to humans and the evidence does not support classification with regard to its carcinogenic potential’. Addendum 1 (the BfR Addendum) of the RAR5 discusses the scientific rationale for differing from the IARC WG conclusion. Serious flaws in the scientific evaluation in the RAR incorrectly characterise the potential for a carcinogenic hazard from exposure to glyphosate. Since the RAR is the basis for the European Food Safety Agency (EFSA) conclusion,4 it is critical that these shortcomings are corrected. EFSA concluded ‘that there is very limited evidence for an association between glyphosate-based formulations …

155 citations

Journal ArticleDOI
TL;DR: The present study supports the existing evidence that long-term exposure to traffic-related air pollution increases the risk of cardiopulmonary as well as LC mortality, and provides additional evidence for adverse effects on intracerebral hemorrhage aswell as ischemic stroke.

89 citations

Journal ArticleDOI
TL;DR: A protective effect of physical activity on all-cause and CVD mortality among Japanese elderly people with pre-existing disease is suggested.

87 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.
Abstract: Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests.

23,203 citations

Journal ArticleDOI
TL;DR: March 5, 2019 e1 WRITING GROUP MEMBERS Emelia J. Virani, MD, PhD, FAHA, Chair Elect On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.
Abstract: March 5, 2019 e1 WRITING GROUP MEMBERS Emelia J. Benjamin, MD, ScM, FAHA, Chair Paul Muntner, PhD, MHS, FAHA, Vice Chair Alvaro Alonso, MD, PhD, FAHA Marcio S. Bittencourt, MD, PhD, MPH Clifton W. Callaway, MD, FAHA April P. Carson, PhD, MSPH, FAHA Alanna M. Chamberlain, PhD Alexander R. Chang, MD, MS Susan Cheng, MD, MMSc, MPH, FAHA Sandeep R. Das, MD, MPH, MBA, FAHA Francesca N. Delling, MD, MPH Luc Djousse, MD, ScD, MPH Mitchell S.V. Elkind, MD, MS, FAHA Jane F. Ferguson, PhD, FAHA Myriam Fornage, PhD, FAHA Lori Chaffin Jordan, MD, PhD, FAHA Sadiya S. Khan, MD, MSc Brett M. Kissela, MD, MS Kristen L. Knutson, PhD Tak W. Kwan, MD, FAHA Daniel T. Lackland, DrPH, FAHA Tené T. Lewis, PhD Judith H. Lichtman, PhD, MPH, FAHA Chris T. Longenecker, MD Matthew Shane Loop, PhD Pamela L. Lutsey, PhD, MPH, FAHA Seth S. Martin, MD, MHS, FAHA Kunihiro Matsushita, MD, PhD, FAHA Andrew E. Moran, MD, MPH, FAHA Michael E. Mussolino, PhD, FAHA Martin O’Flaherty, MD, MSc, PhD Ambarish Pandey, MD, MSCS Amanda M. Perak, MD, MS Wayne D. Rosamond, PhD, MS, FAHA Gregory A. Roth, MD, MPH, FAHA Uchechukwu K.A. Sampson, MD, MBA, MPH, FAHA Gary M. Satou, MD, FAHA Emily B. Schroeder, MD, PhD, FAHA Svati H. Shah, MD, MHS, FAHA Nicole L. Spartano, PhD Andrew Stokes, PhD David L. Tirschwell, MD, MS, MSc, FAHA Connie W. Tsao, MD, MPH, Vice Chair Elect Mintu P. Turakhia, MD, MAS, FAHA Lisa B. VanWagner, MD, MSc, FAST John T. Wilkins, MD, MS, FAHA Sally S. Wong, PhD, RD, CDN, FAHA Salim S. Virani, MD, PhD, FAHA, Chair Elect On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee

5,739 citations

Journal ArticleDOI
TL;DR: The Statistical Update represents the most up-to-date statistics related to heart disease, stroke, and the cardiovascular risk factors listed in the AHA's My Life Check - Life’s Simple 7, which include core health behaviors and health factors that contribute to cardiovascular health.
Abstract: Each chapter listed in the Table of Contents (see next page) is a hyperlink to that chapter. The reader clicks the chapter name to access that chapter. Each chapter listed here is a hyperlink. Click on the chapter name to be taken to that chapter. Each year, the American Heart Association (AHA), in conjunction with the Centers for Disease Control and Prevention, the National Institutes of Health, and other government agencies, brings together in a single document the most up-to-date statistics related to heart disease, stroke, and the cardiovascular risk factors listed in the AHA’s My Life Check - Life’s Simple 7 (Figure1), which include core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure [BP], and glucose control) that contribute to cardiovascular health. The Statistical Update represents …

5,102 citations

Journal ArticleDOI
TL;DR: This year's edition of the Statistical Update includes data on the monitoring and benefits of cardiovascular health in the population, metrics to assess and monitor healthy diets, an enhanced focus on social determinants of health, a focus on the global burden of cardiovascular disease, and further evidence-based approaches to changing behaviors, implementation strategies, and implications of the American Heart Association’s 2020 Impact Goals.
Abstract: Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports on the most up-to-date statistics related to heart disease, stroke, and cardiovas...

5,078 citations

Journal ArticleDOI
TL;DR: This book is dedicated to the memory of those who have served in the armed forces and their families during the conflicts of the twentieth century.

2,628 citations